IT'S YOUR SKIN

Learn more about TREMFYA®
Joe, Real TREMFYA® Patient

If you’re looking at TREMFYA® as a treatment option for your moderate to severe plaque psoriasis, let us help. The first FDA-approved medication of its kind, TREMFYA® selectively blocks interleukin-23 (IL-23), one of the key proteins thought to be responsible for the symptoms of plaque psoriasis.

Let’s talk about clearer skin

If you’ve tried steroids, topical creams or phototherapy and still didn’t get the results you wanted, TREMFYA® may be the treatment for you.

UNCOVER CLEARER SKIN

In clinical studies at 16 weeks, at least 7 out of 10 patients with moderate to severe plaque psoriasis saw at least 90% clearer skin and more than 8 out of 10 were rated clear or almost clear.

SUPERIOR SKIN CLEARANCE

In clinical studies, TREMFYA® was proven superior to Humira® (adalimumab) in providing clearer skin.*

PLAQUE PSORIASIS SYMPTOMS

More people using TREMFYA® were free from symptoms, including itching, skin tightness, burning, stinging, and pain at 24 weeks compared with those using Humira®.

STINGING

SKIN TIGHTNESS

ITCHING

BURNING

PAIN

DOSING PROFLE

TREMFYA® is given as a single 100 mg injection under your skin once every 8 weeks, after 2 starter doses at weeks 0 and 4. That means you don’t have to think about your next scheduled maintenance dose for almost two months between injections.

FIRST 52 WEEKS OF THERAPY